Skip to main content
OpenTrials

Clinical trial condition

Melanoma

Explore clinical trials studying Melanoma. Study availability and eligibility vary by location and protocol.

1,012 public trials 175 recruiting studies
Refine in advanced search Browse all conditions

Melanoma trial results

Completed

Ph1b/2 Dose-Escalation Study of Entinostat With Pembrolizumab in Non-small Cell Lung Cancer (NSCLC) With Expansion Cohorts in NSCLC, Melanoma, and Colorectal Cancer (CRC)

NCT02437136

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +19 more
Locations
  • Yale University New Haven, Connecticut, United States
  • Emory University Atlanta, Georgia, United States
  • University of Maryland, Marlene and Stewart Greenbaum Cancer Center Baltimore, Maryland, United States
  • Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins Baltimore, Maryland, United States
View Trial Details
Completed

BRAF-/MEK-Inhibition With Dabrafenib and Trametinib in Melanoma Patients

NCT03944356

Conditions
Melanoma, Neoplasms, Neoplasms by Histologic Type, +9 more
Locations
  • Elbe Kliniken Stade - Buxtehude GmbH Buxtehude, Lower Saxony, Germany
  • Universitätsklinikum Essen, Klinik und Poliklinik für Dermatologie, Venerologie und Allergologie Essen, North Rhine-Westphalia, Germany
  • Universitätsklinik Kiel, Klinik für Dermatologie, Venerologie und Allergologie Kiel, Schleswig-Holstein, Germany
  • Katholisches Klinikum Bochum Bochum, Germany
View all 36 locations
View Trial Details
Completed

NAUTILUS: OKI-179 Plus Binimetinib in Patients with Advanced Solid Tumors in the RAS Pathway (Phase 1b) and NRAS-mutated Melanoma (Phase 2)

NCT05340621

Conditions
Melanoma, NRAS Gene Mutation, Neoplasms, +11 more
Locations
  • CTCA Phoenix, part of City of Hope Phoenix, Arizona, United States
  • University of California, San Francisco San Francisco, California, United States
  • University of Florida Health Cancer Center Gainesville, Florida, United States
  • Emory University Winship Cancer Institute Atlanta, Georgia, United States
View Trial Details
Completed

PRospective REgistry of Advanced Stage CancER (PREFER) Patients to Assess Prevalence of Actionable Biomarkers and Driver Mutations to Address Disparities in Precision Medicine

NCT05697198

Conditions
Adnexal Diseases, Breast Cancer, Breast Diseases, +68 more
Locations
  • Clinical Site Fort Payne, Alabama, United States
  • Clinical Site Orange City, Florida, United States
  • Clinical Site Stuart, Florida, United States
  • Clinical Site Dublin, Georgia, United States
View Trial Details
Completed

A Study to Compare Nivolumab Administered Subcutaneously vs Intravenous in Melanoma Participants Following Complete Resection

NCT05297565

Conditions
Melanoma, Neoplasms, Neoplasms by Histologic Type, +9 more
Locations
  • Local Institution - 0004 Fort Wayne, Indiana, United States
  • Local Institution - 0044 Knoxville, Tennessee, United States
  • Local Institution - 0038 Coffs Harbour, New South Wales, Australia
  • Local Institution - 0003 Wollongong, New South Wales, Australia
View all 16 locations
View Trial Details

Related conditions